BNP Paribas Financial Markets Makes New $1.31 Million Investment in Option Care Health, Inc. (NASDAQ:OPCH)

BNP Paribas Financial Markets purchased a new stake in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 56,488 shares of the company's stock, valued at approximately $1,311,000.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. JPMorgan Chase & Co. raised its position in Option Care Health by 29.6% in the 4th quarter. JPMorgan Chase & Co. now owns 1,511,403 shares of the company's stock valued at $35,065,000 after buying an additional 344,875 shares during the last quarter. MetLife Investment Management LLC lifted its position in shares of Option Care Health by 7.8% in the fourth quarter. MetLife Investment Management LLC now owns 197,219 shares of the company's stock worth $4,575,000 after purchasing an additional 14,311 shares in the last quarter. Charles Schwab Investment Management Inc. boosted its holdings in Option Care Health by 6.2% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 2,510,131 shares of the company's stock worth $58,235,000 after purchasing an additional 147,054 shares during the last quarter. Global Alpha Capital Management Ltd. grew its position in Option Care Health by 38.1% in the fourth quarter. Global Alpha Capital Management Ltd. now owns 68,810 shares of the company's stock valued at $1,596,000 after purchasing an additional 18,992 shares in the last quarter. Finally, Y Intercept Hong Kong Ltd bought a new position in Option Care Health in the fourth quarter valued at $327,000. 98.05% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

OPCH has been the subject of a number of recent research reports. Barrington Research restated an "outperform" rating and set a $38.00 price objective on shares of Option Care Health in a research note on Wednesday, April 30th. UBS Group raised Option Care Health from a "neutral" rating to a "buy" rating and increased their price objective for the company from $38.00 to $40.00 in a report on Wednesday, April 30th. JMP Securities reissued a "market outperform" rating and issued a $36.00 price objective on shares of Option Care Health in a research report on Tuesday, April 22nd. Finally, JPMorgan Chase & Co. lifted their price target on Option Care Health from $40.00 to $41.00 and gave the stock an "overweight" rating in a report on Thursday, March 6th. One equities research analyst has rated the stock with a hold rating and seven have assigned a buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $35.50.

Insider Transactions at Option Care Health

In related news, insider Michael Bavaro sold 30,996 shares of the stock in a transaction that occurred on Friday, February 28th. The stock was sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the sale, the insider now owns 44,974 shares of the company's stock, valued at $1,495,835.24. This represents a 40.80% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Insiders own 0.64% of the company's stock.

Option Care Health Stock Performance

NASDAQ OPCH traded down $0.62 on Friday, reaching $31.41. The stock had a trading volume of 836,498 shares, compared to its average volume of 1,862,931. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32. The company has a market cap of $5.14 billion, a P/E ratio of 26.39, a price-to-earnings-growth ratio of 2.30 and a beta of 0.76. The firm has a fifty day moving average of $32.99 and a two-hundred day moving average of $29.39. Option Care Health, Inc. has a 1-year low of $21.39 and a 1-year high of $35.53.

Option Care Health (NASDAQ:OPCH - Get Free Report) last released its quarterly earnings results on Tuesday, April 29th. The company reported $0.40 EPS for the quarter, beating the consensus estimate of $0.36 by $0.04. Option Care Health had a net margin of 4.37% and a return on equity of 15.30%. The business had revenue of $1.33 billion for the quarter, compared to the consensus estimate of $1.26 billion. During the same period in the prior year, the company posted $0.26 earnings per share. Option Care Health's revenue was up 16.3% compared to the same quarter last year. On average, equities research analysts anticipate that Option Care Health, Inc. will post 1.22 EPS for the current year.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.